Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Sep-12 4:48 PM View:  | Allos Therapeutics, Inc. (ALTH) | 04-Sep-12 | Disposition (change in control) | 285,113 | $1.82 | $518,906.00 | (100%) 285.11K to 0 | (< 1%) |
| 13-Jul-12 4:40 PM View: | Allos Therapeutics, Inc. (ALTH) | 11-Jul-12 | Market Sale (Planned) | 697 | $1.78 | $1,241.50 | (< 1%) 285.81K to 285.11K | < 1% |
| 01-Mar-12 6:12 PM View: | Allos Therapeutics, Inc. (ALTH) | 01-Mar-12 | Market Sale (Planned) | 3,960 | $1.48 | $5,865.95 | (1%) 289.77K to 285.81K | (< 1%) |
| 01-Mar-12 6:12 PM View: | Allos Therapeutics, Inc. (ALTH) | 29-Feb-12 | Market Sale (Planned) | 3,894 | $1.52 | $5,934.85 | (1%) 293.66K to 289.77K | 2% |
| 01-Mar-12 6:12 PM View: | Allos Therapeutics, Inc. (ALTH) | 28-Feb-12 | Grant | 135,545 | -- | -- | 86% 158.12K to 293.66K | |
| 27-Feb-12 5:41 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Feb-12 | Market Sale (Planned) | 1,645 | $1.58 | $2,599.10 | (1%) 159.76K to 158.12K | (< 1%) |
| 17-Nov-11 5:05 PM View: | Allos Therapeutics, Inc. (ALTH) | 16-Nov-11 | Market Sale (Planned) | 140 | $1.43 | $200.80 | (< 1%) 159.9K to 159.76K | |
| 17-Nov-11 5:05 PM View: | Allos Therapeutics, Inc. (ALTH) | 15-Nov-11 | Market Sale (Planned) | 8,033 | $1.44 | $11,575.60 | (5%) 167.94K to 159.9K | |
| 13-Jul-11 4:21 PM View: | Allos Therapeutics, Inc. (ALTH) | 11-Jul-11 | Market Sale (Planned) | 730 | $2.06 | $1,505.26 | (< 1%) 168.67K to 167.94K | < 1% |
| 02-Mar-11 5:09 PM View: | Allos Therapeutics, Inc. (ALTH) | 28-Feb-11 | Grant | 65,000 | -- | -- | 63% 103.67K to 168.67K | |
| 25-Feb-11 5:26 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Feb-11 | Market Sale (Planned) | 1,570 | $3.25 | $5,105.33 | (1%) 105.24K to 103.67K | 1% |
| 22-Oct-10 5:20 PM View: | Allos Therapeutics, Inc. (ALTH) | 20-Oct-10 | Grant | 78,300 | -- | -- | 291% 26.94K to 105.24K |